Sertraline Reduces Albuminuria by Interfering with Caveolae-Mediated Endocytosis through Glomerular Endothelial and Epithelial Cells
Sertraline Reduces Albuminuria by Interfering with Caveolae-Mediated Endocytosis through Glomerular Endothelial and Epithelial Cells
复制标题
舍曲林通过干扰肾小球内皮细胞和上皮细胞小凹介导的内吞作用来减少蛋白尿
DOI:
10.1159/000503917
复制
发表时间:
2019
影响因子:
4.2
通讯作者:
Nitta Kosaku
中科院分区:
文献类型:
--
作者:
Moriyama Takahito;Karasawa Kazunori;Hasegawa Fumio;Uchida Keiko;Nitta Kosaku
IntroductionPreviously, we reported the caveolae-mediated intracellular trafficking pathway of albumin through glomerular endothelial cells (GEnCs) as a new etiological hypothesis of urinary albumin excretion. The selective serotonin reuptake inhibitor, sertraline (Ser), inhibits dynamin, which plays a pivotal role in the fission of caveolae from the cell membrane during caveolae endocytosis.ObjectiveIn this study, we evaluated whether Ser reduces albuminuria levels by interfering with albumin endocytosis through caveolae into GEnCs and podocytes as a novel treatment for glomerulonephritis.MethodsAfter treating the cells with Ser, albumin and caveolin-1 (Cav-1) expression levels were evaluated by immunofluorescence (IF) and western blot (WB) analyses. The albuminuria level was determined by histology in a puromycin aminonucleoside (PAN)-induced nephrotic syndrome mouse model (PAN mice) treated with or without Ser.ResultsIF and WB analyses showed that the albumin expression level was significantly decreased by Ser treatment; however, Cav-1 expression was not decreased in GEnCs or podocytes based on the IF results. In PAN mice treated with or without Ser, Cav-1 expression increased, and the foot process effacement of podocytes and swelling of GEnCs were observed. However, proteinuria levels were not increased in PAN mice treated with Ser relative to that in normal control mice (p= 0.17), and a significant increase was observed in PAN mice without Ser treatment (p= 0.0027).ConclusionsSer interfered with albumin internalization through the caveolae into GEnCs and podocytes and reduced albuminuria. Dynamin inhibitors may serve as a novel therapeutic option for reducing albuminuria in glomerulonephritis.
登录
查看更多内容
影响因子:
3.1
作者:
Saiz-Rodriguez, Miriam;Belmonte, Carmen;Abad-Santos, Francisco
通讯作者:
Abad-Santos, Francisco
DOI:
10.1152/ajprenal.00532.2013
发表时间:
2014-05-01
影响因子:
4.2
作者:
Dobrinskikh, Evgenia;Okamura, Kayo;Blaine, Judith
通讯作者:
Blaine, Judith
影响因子:
2.3
作者:
K. Sandvig;Simona Kavaliauskiene;T. Skotland
通讯作者:
T. Skotland
影响因子:
0.7
作者:
Zahed NS;Sharifi M;Karimi M;Nikbakht H
通讯作者:
Nikbakht H
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
Takahashi;K.;池田裕美子;Kiyofumi Takahashi.
通讯作者:
Kiyofumi Takahashi.